- Home
- KULR vs ORMP Comparison
KULR vs ORMP Comparison
Compare KULR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KULR | ORMP |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.8M | 141.3M |
| IPO Year | 2016 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KULR | ORMP |
|---|---|---|
| Price | $2.10 | $3.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 101.0K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 7.29% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 1.50 |
| Revenue | $1,274,028.00 | ★ $2,000,000.00 |
| Revenue This Year | $64.40 | N/A |
| Revenue Next Year | $105.13 | N/A |
| P/E Ratio | ★ N/A | $2.28 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $0.73 | $1.82 |
| 52 Week High | $7.49 | $3.76 |
Technical Indicators
Market Signals| Indicator | KULR | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 34.03 | 50.56 |
| Support Level | $0.73 | $3.21 |
| Resistance Level | $3.16 | $3.72 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 18.68 | 42.22 |
Price Performance
Historical ComparisonAbout KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.